Avanos Medical, Inc. Sustainability Profile
Avanos Medical, Inc., headquartered in the United States, is a prominent player in the medical device industry, specialising in innovative solutions for pain management and surgical care. Founded in 2014, the company has rapidly established itself as a leader in its field, focusing on advanced technologies that enhance patient outcomes and streamline healthcare processes. With a diverse portfolio that includes products for pain management, wound care, and respiratory health, Avanos Medical distinguishes itself through its commitment to quality and innovation. The company operates in key regions across North America and Europe, ensuring a broad reach in delivering its unique offerings. Notable achievements include significant advancements in regional anaesthesia and the development of proprietary devices that improve procedural efficiency. Avanos Medical continues to solidify its market position by prioritising patient-centric solutions and fostering strong partnerships within the healthcare community.
DitchCarbon Score
How does Avanos Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Avanos Medical, Inc.'s score of 32 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Avanos Medical, Inc.'s reported carbon emissions
In 2024, Avanos Medical, Inc. reported total carbon emissions of approximately 14,112,150 kg CO2e, with Scope 1 emissions accounting for about 1,458,070 kg CO2e and Scope 2 emissions at approximately 12,654,080 kg CO2e. This represents a slight decrease from 2023, where total emissions were about 14,457,820 kg CO2e, with Scope 1 emissions of approximately 1,786,730 kg CO2e and Scope 2 emissions of about 12,671,090 kg CO2e. Avanos has not set specific reduction targets or initiatives as part of their climate commitments, nor do they have any emissions data for Scope 3. The company’s emissions data is self-reported and does not cascade from any parent organisation. Overall, Avanos Medical, Inc. is actively monitoring its carbon footprint, focusing on Scope 1 and Scope 2 emissions, while continuing to explore avenues for future climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 1,786,730 | 0,000,000 |
| Scope 2 | 12,671,090 | 00,000,000 |
| Scope 3 | - | - |
How Carbon Intensive is Avanos Medical, Inc.'s Industry?
How Carbon Intensive is Avanos Medical, Inc.'s Location?
Avanos Medical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Avanos Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
